Graduate Department, BengBu Medical College, BengBu, Anhui Province, China.
Key Laboratory of Tumour Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang Province, China.
J Cell Mol Med. 2019 Aug;23(8):5037-5047. doi: 10.1111/jcmm.14361. Epub 2019 Jun 17.
MicroRNAs (miRNAs) are key regulators in the tumour growth and metastasis of human hepatocellular carcinoma (HCC). Increasing evidence suggests that miR-301b-3p functions as a driver in various types of human cancer. However, the expression pattern of miR-301b-3p and its functional role as well as underlying molecular mechanism in HCC remain poorly known. Our study found that miR-301b-3p expression was significantly up-regulated in HCC tissues compared to adjacent non-tumour tissues. Clinical association analysis revealed that the high level of miR-301b-3p closely correlated with large tumour size and advanced tumour-node-metastasis stages. Importantly, the high miR-301b-3p level predicted a prominent poorer overall survival of HCC patients. Knockdown of miR-301b-3p suppressed cell proliferation, led to cell cycle arrest at G2/M phase and induced apoptosis of Huh7 and Hep3B cells. Furthermore, miR-301b-3p knockdown suppressed tumour growth of HCC in mice. Mechanistically, miR-301b-3p directly bond to 3'UTR of vestigial like family member 4 (VGLL4) and negatively regulated its expression. The expression of VGLL4 mRNA was down-regulated and inversely correlated with miR-301b-3p level in HCC tissues. Notably, VGLL4 knockdown markedly repressed cell proliferation, resulted in G2/M phase arrest and promoted apoptosis of HCC cells. Accordingly, VGLL4 silencing rescued miR-301b-3p knockdown attenuated HCC cell proliferation, cell cycle progression and apoptosis resistance. Collectively, our results suggest that miR-301b-3p is highly expressed in HCC. miR-301b-3p facilitates cell proliferation, promotes cell cycle progression and inhibits apoptosis of HCC cells by repressing VGLL4.
微小 RNA(miRNAs)是人类肝细胞癌(HCC)肿瘤生长和转移的关键调节因子。越来越多的证据表明,miR-301b-3p 在各种类型的人类癌症中起驱动作用。然而,miR-301b-3p 的表达模式及其在 HCC 中的功能作用和潜在分子机制仍知之甚少。我们的研究发现,miR-301b-3p 在 HCC 组织中的表达明显高于相邻非肿瘤组织。临床关联分析表明,高水平的 miR-301b-3p 与大肿瘤大小和晚期肿瘤-淋巴结-转移分期密切相关。重要的是,高水平的 miR-301b-3p 预测 HCC 患者总体生存率显著降低。miR-301b-3p 的敲低抑制细胞增殖,导致 Huh7 和 Hep3B 细胞周期停滞在 G2/M 期,并诱导细胞凋亡。此外,miR-301b-3p 的敲低抑制 HCC 在小鼠中的肿瘤生长。在机制上,miR-301b-3p 直接与 vestigial like family member 4(VGLL4)的 3'UTR 结合并负调控其表达。在 HCC 组织中,VGLL4 mRNA 的表达下调且与 miR-301b-3p 水平呈负相关。值得注意的是,VGLL4 的敲低显著抑制细胞增殖,导致 G2/M 期阻滞并促进 HCC 细胞凋亡。因此,VGLL4 沉默挽救了 miR-301b-3p 敲低减弱的 HCC 细胞增殖、细胞周期进程和抗凋亡能力。总之,我们的结果表明,miR-301b-3p 在 HCC 中高度表达。miR-301b-3p 通过抑制 VGLL4 促进 HCC 细胞增殖、促进细胞周期进程和抑制细胞凋亡。